Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
6.01%
operating margin TTM
6.38%
revenue TTM
313.12 Thousand
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | 88.51 |
| peg ratio | 0.12 |
| price to book ratio | 5.94 |
| price to sales ratio | 5.29 |
| enterprise value multiple | 76.78 |
| price fair value | 5.94 |
profitability ratios | |
|---|---|
| gross profit margin | 74.24% |
| operating profit margin | 6.38% |
| pretax profit margin | 8.13% |
| net profit margin | 6.01% |
| return on assets | 5.04% |
| return on equity | 7.46% |
| return on capital employed | 6.48% |
liquidity ratios | |
|---|---|
| current ratio | 3.85 |
| quick ratio | 3.85 |
| cash ratio | 1.41 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 10.58 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.38 |
| cash per share | 4.78 |
| operating cash flow per share | 1.40 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 10.58 |
| short term coverage ratios | 38.15 |
| capital expenditure coverage ratio | 91.19 |
Frequently Asked Questions
When was the last time Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) reported earnings?
Kiniksa Pharmaceuticals, Ltd. (KNSA) published its most recent earnings results on 28-10-2025.
What is Kiniksa Pharmaceuticals, Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)'s trailing twelve months ROE is 7.46%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Kiniksa Pharmaceuticals, Ltd. (KNSA) currently has a ROA of 5.04%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KNSA's net profit margin stand at?
KNSA reported a profit margin of 6.01% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KNSA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.85 in the most recent quarter. The quick ratio stood at 3.85, with a Debt/Eq ratio of 0.02.